key: cord-0724529-0zgcj3zd
authors: Stefanovic, A.; Reich, N.; Lowe, C. F.; Puddicombe, D.; Matic, N.; Greiner, J.; Simons, J.; Leung, V.; Chu, T.; Naik, H.; Myles, N.; Burns, L.; Romney, M. G.; Ritchie, G.; Champagne, S.; Dooley, K.; Sekirov, I.
title: Diagnostic accuracy of RT-PCR for detection of SARS-CoV-2 compared to a composite reference standard in hospitalized patients
date: 2021-02-22
journal: nan
DOI: 10.1101/2021.02.18.21252016
sha: ad0841c9fc8a6449baf8e7251bb787600f730125
doc_id: 724529
cord_uid: 0zgcj3zd

Background: COVID 19 caused by the novel coronavirus SARS CoV 2 has caused the greatest public health emergency of our time. Accurate laboratory detection of the virus is critical in order to contain the spread. Although real time polymerase chain reaction (PCR) has been the cornerstone of laboratory diagnosis, there have been conflicting reports on the diagnostic accuracy of this method. Methods: A retrospective review was performed on all hospitalized patients tested for SARS CoV 2 (at St. Pauls Hospital in Vancouver, BC) from March 13 to April 12, 2020. Diagnostic accuracy of initial PCR on nasopharyngeal (NP) swabs was determined against a composite reference standard which included a clinical assessment of the likelihood of COVID 19 by medical experts, initial and repeat PCR, and post-hoc serological testing. Results: A total of 323 patients were included in the study, 33 (10.2%) tested positive and 290 (89.8%) tested negative by initial PCR. Patients testing positive were more likely to exhibit features of cough (66.7% vs 39.3%), shortness of breath (63.6% vs 35.9%), fever (72.7% vs 27.6%), radiographic findings (83.3% vs 39.6%) and severe outcomes including ICU admission (24.2% vs 9.7%) and mortality (21.2% vs 6.2%) compared to patients testing negative. Serology was performed on 90 patients and correlation between serology and PCR was 98.9%. There were 90 patients included in the composite reference standard. Compared to the composite reference standard, initial PCR had sensitivity of 94.7% (95% CI 74.0 to 99.9%), specificity of 100% (95% CI 94.9 to 100%), positive predictive value of 100% (95% CI 81.5 to 100%) and a negative predictive value of 98.6% (95% CI 92.5 to 100%). Discussion: Our study showed high sensitivity of PCR on NP swab specimens when compared to composite reference standard in hospitalized patients. High correlation of PCR with serological testing further increased confidence in the diagnostic reliability of properly collected NP swabs.

and high probability cases presented with compatible clinical features, radiological findings, no 126 alternative diagnosis and/or an epidemiologic link to a known COVID-19 case. Patients deemed 127 moderate to high risk for COVID-19 on initial assessment, underwent further review by an 128 "expert panel" consisting of two internal medicine specialists caring for patients on dedicated 129 COVID-19 hospital units. Any discordance in "expert" assessment was reviewed by an 130 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 22, 2021. ;  https://doi.org/10.1101/2021.02.18.21252016 doi: medRxiv preprint infectious disease specialist. Reviewers were not blinded to the PCR test result as it was reported 131 in the electronic medical chart but were blinded to the serological result. 132 Composite reference standard 133 The composite reference standard included the clinical assessment, any PCR result and serology. 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 

198 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted [23] . CT chest for primary screening or 218 diagnosis of COVID-19 is not helpful in low prevalence setting due to significant rate of false 219 positives [24] . Even though radiological findings may be helpful as an added diagnostic tool in 220 settings of high COVID-19 incidence, they not only lack specificity but can also be falsely 221 negative early after symptom onset [11] [15] .

The estimated clinical sensitivity of NP swab PCR of 94.3% from this study echoes a study by 223 Miller et al. who similarly ascertained PCR sensitivity of 95% in the first 5 days post-symptom 224 onset in hospitalized patients [25] . Earlier studies have suggested clinical sensitivity of molecular 225 assays to be in the range of 70% [26] [27] [28] . One of the earlier studies was a letter by Wang et 226 al which included only 8 "nasal swabs" in their analysis [26] . While there is much 227 interchangeable use of "nasal" and "nasopharyngeal (NP) swabs" in the literature, these are 228 considerably different collection methods with "nasal swabs" being much less sensitive [29] [30]

[31] [32] . Our group has further demonstrated the importance of proper specimen collection 230 method with increased rate of false negative results in inadequately collected NP swabs [32] . 231 Yang et al. (pending peer review) also reported low sensitivity of PCR, however they similarly 232 included nasal swabs and utilized molecular assay with lower analytical sensitivity [27] [33] 233 [34] . Although their study had limited data on patient characteristics and confirmation of 234 COVID-19 diagnosis, it did suggest improved accuracy of lower respiratory tract specimens in 235 diagnosis of more severe cases of COVID-19 [27] . Indeed pathogenesis of SARS-COV-2 236 demonstrates that the virus, once acquired, replicates in the upper respiratory tract and in a subset 237 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 22, 2021. ; https://doi.org/10.1101/2021.02.18.21252016 doi: medRxiv preprint of patients advances and propagates in the lower respiratory airways and alveoli causing a more 238 severe presentation [35] . However, there are practical challenges in obtaining lower respiratory 239 tract specimens due to difficulty with sputum production or concerns of aerosol generation with 240 bronchoscopy. In our study, only in a small proportion (3.4%) of patients had lower respiratory 241 swabs collected.

There were 2 false negative cases on initial PCR converting to positive on subsequent testing. In 243 the first case, the initial negative NP swab was taken 24 hrs after symptom onset and became suffered from a high risk of bias and a lack of validation, therefore we opted against using them 258 in our study [39] . Our model, although practical, is affected by the subjective nature of clinical 259 likelihood assessment. Expert group inter-assessor reliability was 68.4% in assigning patients to 260 moderate or high clinical likelihood groups. The moderate agreement could be reflective of non-261 specific nature of COVID-19 presentation as well as the risk attitudes of assessors [40] . In order 262 to mitigate some of this subjectivity, we assigned patients deemed moderate or high likelihood 263 category as positive on clinical assessment and cases in low likelihood category as negative.

PCR and serology are incorporated as objective parts of the model; however, the evaluators were 265 blinded to serology but not PCR results, which may have introduced bias in the clinical 266 assessment.

Serological immunoassays have more recently become an adjunct to testing for COVID-19 [12] 268 [41] . Similar to nucleic acid testing, serological diagnostic accuracy is determined by the target 269 antigen and timing of collection. For example, antibodies (Abs) targeting the SARS-CoV-2 N 270 protein are detectable earlier than antibodies against S protein, and Anti-N-protein IgG Abs tend 271 to decrease earlier in the disease course than Anti-S-protein IgG Abs [42] . Our study criteria of In summary, the risk of false-negative results with nucleic acid amplification tests is mostly 306 related to pre-analytical factors such as timing of collection, the quality of sampling method and 307 specimen type [36] [42] . Molecular testing on NP swabs has a high clinical sensitivity and 308 excellent correlation with serology. As recommended by IDSA guidelines, cases with high 309 clinical likelihood of COVID-19 and repeatedly negative NP swab PCR should undergo testing 310 with serology to further enhance diagnostic yield [47] , and a single PCR result cannot be 311 interpreted in isolation without full clinical assessment of the case. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted February 22, 2021. ; https://doi.org/10.1101/2021.02.18.21252016 doi: medRxiv preprint

Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases from the Chinese Center for Disease Control and PRevention

WHO Situation Report

Mild or Moderate Covid-19

China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China

Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Penumonia in Wuhan, China

Clinical features of patients infected with 2019 nocel coronavirus in Wuhan, China

China Novel Coronaviurs Investigating and Research Team: A Novel Coronavirus from Patients with Pnumonia in China

Relationship to Negative RT-PCR Testing

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Antibody responses to SARS-CoV-2 in patients with COVID-19

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospectice cohort study

Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection

Stata statistical software: release 14

Statistical methods for assessing observer variability in clinical measures

Gender Differences in Patients with COVID-19: Focus on Severity and Mortality

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study

Comparative accuracy of oropharyngeal and nasopharyngeal swabs for diagnosis of COVID-19

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR

Diagnostic Performance of CT and Reverse Transcriptase Polymerase Chain Reaction for Coronavirus Disease 2019: A Meta-Analysis

Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

False Negative Tests for SARS-CoV-2 Infection -Challenges and Implications

WHO guidelines for the collection of human specimens for laboratory diagnosis of avian influenza infection

Nasal swab sampling for SARs-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage

Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results

Letter to the editor: SARS-CoV-2 detection by real-time RT-PCR

Pathogenesis of COVID-19 from a cell biology perspective

Variation in False-NEgative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, Janurary -March 2020: retrospective cohort study

Temporal dynamics in viral shedding and transmissibility of COVID-19

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Risk attitudes and personality traits predict perceptions of benefits and risks for medicinal products: a field study of European medical assessors

In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends

Diagnostic Strategies for SARS-CoV-2 infection and interpretation of microbiological results

Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease

Sensitivity in Detection of Antibodies to Nucleocapsiod and Spike Prtoetins of Severe Acute Respiratroy Syndrome Coronavirus 2 in Patients with Coronavirus Disease

Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons

Virological assessment of hospitalized patients with COVID-2019

DEtection of 2019 novel coronavirus (2019-nCoV) by realtime RT-PCR

CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnositc panel

Commercial SARS-CoV-2 Molecular Assays: Superior Analytical Sensitivity of cobas SARS-CoV-2 Relative to NxTAG Cov Extended Panel and ID NOW COVID-19 Test

Clinical Performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 Detection in Nasopharyngeal Specimens from COVID-19 Patients in Hong Kong

Comparison of nasal and nasopharyngeal swabs for influenza detection in adults

Longitudinal Monitoring of SARS-CoV-2 IgM and IgG Seropositvity to Detect COVID-19

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

A recurrent mutation at position 26,340 of SARS-CoV-2 is associated with failure of the E-gene qRT-PCR utilized in a commercial dual-target diagnostic assay

EUA authorized serology test performance

Lymphopenia in severe coronavirus disease -2019 (COVID-19): systematic review and meta-analysis

WHO Emergency Use Assessment Coronavirus disease (COVID-19) IVDs